David A. Schoenfeld

1.9k total citations
38 papers, 1.4k citations indexed

About

David A. Schoenfeld is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David A. Schoenfeld has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 14 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David A. Schoenfeld's work include Cancer Immunotherapy and Biomarkers (11 papers), Renal cell carcinoma treatment (7 papers) and Immunotherapy and Immune Responses (4 papers). David A. Schoenfeld is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Renal cell carcinoma treatment (7 papers) and Immunotherapy and Immune Responses (4 papers). David A. Schoenfeld collaborates with scholars based in United States, Germany and China. David A. Schoenfeld's co-authors include D. R. Cox, David Oakes, Shuo Lin, André E. Nel, Saji George, Xiang Wang, Zhaoxia Ji, Sijie Lin, Tian Xia and Yan Zhao and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

David A. Schoenfeld

36 papers receiving 1.4k citations

Peers

Countries citing papers authored by David A. Schoenfeld

Since Specialization

Citations

This map shows the geographic impact of David A. Schoenfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Schoenfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Schoenfeld more than expected).

Fields of papers citing papers by David A. Schoenfeld

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Schoenfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Schoenfeld. The network helps show where David A. Schoenfeld may publish in the future.

Co-authorship network of co-authors of David A. Schoenfeld

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Schoenfeld. A scholar is included among the top collaborators of David A. Schoenfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Schoenfeld. David A. Schoenfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Decoy-resistant IL-18 reshapes the tumor microenvironment and enhances rejection by anti–CTLA-4 in renal cell carcinoma 2024 ·JCI Insight ·David A. Schoenfeld, Dijana Djureinovic, David Su, Lin Zhang, Benjamin Y. Lu, (unknown), Jacqueline E. Mann, John D. Huck, Michael E. Hurwitz, David A. Braun, Lucia B. Jilaveanu, Aaron M. Ring, Harriet M. Kluger	6
2	Update on Biomarkers in Renal Cell Carcinoma 2024 ·American Society of Clinical Oncology Educational Book ·Renée Maria Saliby, Eddy Saad, Soki Kashima, David A. Schoenfeld, David A. Braun	16
3	Melanocortin-1 Receptor Expression as a Marker of Progression in Melanoma 2024 ·JCO Precision Oncology ·David Su, Dijana Djureinovic, David A. Schoenfeld, Bernadette Marquez‐Nostra, Kelly Olino, Lucia B. Jilaveanu, Harriet M. Kluger	4
4	TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3 2024 ·Cancer Immunology Immunotherapy ·(unknown), Lucia B. Jilaveanu, Adebowale Adeniran, David Su, Michael E. Hurwitz, David A. Braun, Harriet M. Kluger, David A. Schoenfeld	2
5	Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma 2024 ·Journal for ImmunoTherapy of Cancer ·David Su, David A. Schoenfeld, (unknown), Raysa Cabrejo, Dijana Djureinovic, Raymond P. Baumann, David L. Rimm, Sajid Khan, Ruth Halaban, Harriet M. Kluger, Kelly Olino, Anjela Galan, James Clune	4
6	GP100 expression is variable in intensity in melanoma 2024 ·Cancer Immunology Immunotherapy ·Jacqueline E. Mann, (unknown), David Su, Adebowale Adeniran, Keiran S.M. Smalley, Dijana Djureinovic, Lucia B. Jilaveanu, David A. Schoenfeld, Harriet M. Kluger	3
7	Lenvatinib or anti-VEGF in combination with anti–PD-1 differentially augments antitumor activity in melanoma 2023 ·JCI Insight ·Thuy Tran, (unknown), Lin Zhang, David A. Schoenfeld, Dijana Djureinovic, Veronica Chiang, (unknown), Sarah A. Weiss, Kelly Olino, Lucia B. Jilaveanu, Harriet M. Kluger	16
8	Outcomes With Combination Pembrolizumab and Axitinib in Second and Further Line Treatment of Metastatic Renal Cell Carcinoma 2023 ·Clinical Genitourinary Cancer ·Nazlı Dizman, Matthew Austin, Bryden Considine, Shlomit Jessel, David A. Schoenfeld, (unknown), Michael E. Hurwitz, Mario Sznol, Harriet M. Kluger	5
9	1070 ‘Decoy-resistant’ IL-18 in combination with CTLA-4 blockade enhances anti-tumor efficacy in preclinical models of renal cell carcinoma 2023 ·SHILAP Revista de lepidopterología ·David A. Schoenfeld, Dijana Djureinovic, Lin Zhang, Jacqueline E. Mann, John D. Huck, Lucia B. Jilaveanu, Aaron M. Ring, Harriet M. Kluger	1
10	Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases 2023 ·Journal for ImmunoTherapy of Cancer ·David A. Schoenfeld, Myrto Moutafi, (unknown), Dijana Djureinovic, Ross D. Merkin, Adebowale Adeniran, David A. Braun, Sabina Signoretti, Toni K. Choueiri, Fabio Parisi, Michael E. Hurwitz, David L. Rimm, Wei Wei, Lucia B. Jilaveanu, Harriet M. Kluger	11
11	A Novel Anti-Tumor Inhibitor Identified by Virtual Screen with PLK1 Structure and Zebrafish Assay 2013 ·PLoS ONE ·Jing Lü, (unknown), Huan Meng, (unknown), David A. Schoenfeld, Chao Che, Ruibin Yan, Hanbing Zhong, Song Li, Shuo Lin	11
12	Expression of the p53 Target CDIP Correlates with Sensitivity to TNFα-Induced Apoptosis in Cancer Cells 2012 ·Cancer Research ·(unknown), David A. Schoenfeld, Fang Tian, Hyung-Gu Kim, Takushi Namba, César Muñoz‐Fontela, Anna Mandinova, Stuart A. Aaronson, Sam W. Lee	9
13	Single molecule profiling of tau gene expression in Alzheimer’s disease 2007 ·Journal of Neurochemistry ·Chris Conrad, Jun Zhu, (unknown), David A. Schoenfeld, Zhide Fang, Martin Ingelsson, Stefan Stamm, George M. Church, Bradley T. Hyman	58
14	PECAM-1 Affects GSK-3β-Mediated β-Catenin Phosphorylation and Degradation 2006 ·American Journal Of Pathology ·Purba Biswas, Sandra Canosa, David A. Schoenfeld, Jonathan D. Schoenfeld, (unknown), (unknown), Jin Zhang, Alfredo Córdova, Bauer E. Sumpio, Joseph A. Madri	62
15	PECAM-1 promotes β-catenin accumulation and stimulates endothelial cell proliferation 2003 ·Biochemical and Biophysical Research Communications ·Purba Biswas, Sandra Canosa, Jonathan D. Schoenfeld, David A. Schoenfeld, Adeline Tucker, Joseph A. Madri	36
16	COMPLEMENT ACTIVATION PRODUCTS IN PLASMA AFTER HEART TRANSPLANTATION IN HUMANS1 2001 ·Transplantation ·(unknown), Winfred W. Williams, GW Dec, (unknown), David A. Schoenfeld, A. Benedict Cosimi, Manuel Pascual	13
17	Polyamines in Human and Rat Milk Influence Intestinal Cell Growth In Vitro 1998 ·Journal of Pediatric Gastroenterology and Nutrition ·G. Capano, Kurt J. Bloch, (unknown), (unknown), David A. Schoenfeld, Paul Harmatz	27
18	The Role of Magnetic Resonance Imaging in Assessing Elevated Intracompartmental Pressure in the Rabbit Hindlimb 1988 ·Plastic & Reconstructive Surgery ·Burt M. Greenberg, (unknown), (unknown), David A. Schoenfeld, James W. May	3
19	Combined modality approach to treatment of malignant gliomas--re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group. 1988 ·PubMed ·(unknown), Marie Diener‐West, Janet K. Horton, Chih‐Hsiang Chang, David A. Schoenfeld, J. Stuart Nelson	143
20	DETERMINING THE LABELING INDEX IN AUTORADIOGRAPHY 1980 ·Cell Proliferation ·David A. Schoenfeld, Robert F. Kallman	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact